Where does David W. Salzman work?

David W. Salzman is Founder of Gatehouse Bio.

What companies did David W. Salzman found?

David W. Salzman founded Gatehouse Bio.

Where did David W. Salzman go to school?

David W. Salzman studied at Yale School of Medicine (Postgraduate Fellowship, Therapeutic Radiology and Translational Science); The University of Connecticut Health Center (Ph.D., Molecular Biology and Biochemistry).

David W. Salzman

Founder

Founder at Gatehouse Bio

Greater Boston

FoundedGatehouse Bio

Find your path to David

73 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.

Karthik ArdhanareeswaranunlockedDavid: together at Yale University School of Medicine (2012–2014)

×7David: together at Yale University School of Medicine

×2David: together at University of Connecticut Health Center

×2David: together at The University of Connecticut Health Center

About

David W. Salzman is the founder and CEO of Gatehouse Bio. An ASCP-certified molecular biologist, he specializes in developing PD/biomarker assays from NGS DNA and RNA sequencing data and in creating qPCR genotyping, RT-qPCR, and dPCR assays for use in tissue and fluid samples. His work has supported go/no-go decisions in pre-clinical and IND-tox studies and contributed to three commercial kits addressing radiation toxicity and anti-PD-1 response and toxicity.

Founder at Gatehouse Bio

Intro paths

→

In turn, David can intro founders to Gatehouse Bio's investors below.

Gatehouse Bio's investors · 1

Claritas CapitalNashville · $2M – $5M checks · since 2020

Experience

Gatehouse BioFounder & CEOcurrent2018 — presentNeedham, MA
MiraDx, Inc.Lead of miRNA Diagnostics and Radiogenomics Program2015 — 2017Los Angeles Metropolitan Area
BiogenScientist2014 — 2016Department of Global Biomarker Discovery & Development
Yale University School of MedicinePostdoctoral Fellow2009 — 2014Department of Therapeutic Radiology
University of Connecticut Health CenterGraduate Research Associate2004 — 2009Department of Molecular Biology and Biochemistry

Skills & more

Assay Development42Protein Chemistry34RNAi25In Vitro20Cell20Molecular Biology29Biochemistry15DNA10Cancer12Immunohistochemistry12Genetics10recombinant DNA technology7

+9 more

Biomarker DiscoveryCell CultureTarget IdentificationIn VivoLaboratoryCell BiologyNucleic Acid EnzymologyWestern BlottingSNP genotyping

From David's professional profile.

Frequently asked questions

Who is David W. Salzman?: David W. Salzman is the founder and CEO of Gatehouse Bio. An ASCP-certified molecular biologist, he specializes in developing PD/biomarker assays from NGS DNA and RNA sequencing data and in creating qPCR genotyping, RT-qPCR, and dPCR assays for use in tissue and fluid samples. His work has supported go/no-go decisions in pre-clinical and IND-tox studies and contributed to three commercial kits addressing radiation toxicity and anti-PD-1 response and toxicity.
Where does David W. Salzman work?: David W. Salzman is Founder of Gatehouse Bio.
What companies did David W. Salzman found?: David W. Salzman founded Gatehouse Bio.
Where did David W. Salzman go to school?: David W. Salzman studied at Yale School of Medicine (Postgraduate Fellowship, Therapeutic Radiology and Translational Science); The University of Connecticut Health Center (Ph.D., Molecular Biology and Biochemistry).

Founder mafias

Yale School of Medicine mafia28

Also came through, then founded or led a company.

Donald IngberDoctor of Medicine - MDFounded Unravel Biosciences +3 Martin L. MayseM.D.Founded Nuvaira +2 Nirav ShahDoctor of Medicine (MD)Founded Sentinel Healthcare +1 Jacob RobinsonDoctor of Medicine - MDFounded VO Health +1 Philip ReillyDoctor of Medicine (M.D.)Founded Luna Genetics +1 Ranjit BindraMD/PhDFounded Cybrexa, Inc. +1

+ 21 more

The University of Connecticut Health Center mafia4

Also came through, then founded or led a company.

Briggs MorrisonMDFounded Crossbow Therapeutics +1 Tim ShannonFounded Quarry Thera Robin Hyde-DeRuyscherPhDFounded Emergo Therapeutics

Same school

Also attended Yale School of Medicine59

Lars PedersenPartner, Chief Financial Officer at Redpoint Ventures Alexi Nazem, MDGeneral Partner at AlleyCorp Elias QuijanoPrincipal at Northpond Ventures Jeffrey LowPartner at Averin Capital Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear Capital Alley (Welsh) OlshanskyAdvisor at Casdin Capital

+ 53 more

Also attended The University of Connecticut Health Center4

Briggs MorrisonEntrepreneur Partner at MPM BioImpact Tim ShannonGeneral Partner at Canaan Partners Matt HammondPartner at RA Capital Robin Hyde-DeRuyscherFounder at Emergo Therapeutics

Shared employers

Also worked at Biogen64

Jigar RaythathaInvestor at Third Rock Ventures Richard RansohoffVenture Partner at Third Rock Ventures Isaiah Baril-DoreInvestor at Index Ventures Roy LobbVenture Partner at Advent Life Sciences Sun AltbachSenior Scientific Advisor at BOLD Longevity John McCabePortfolio Company CFO & COO at Longwood Fund

+ 58 more

Also worked at Yale University School of Medicine72

Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University Partners David Rosenthal, MDVenture Partner at AlleyCorp Alley (Welsh) OlshanskyAdvisor at Casdin Capital Sophie RobinsonSenior Associate at Cure Ventures Michael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures

+ 66 more

Also worked at University of Connecticut Health Center9

Madison LenormandInvestor at Daphni Danielle BradnanSenior Associate at CVS Health Ventures John DriscollVenture Partner at Aegis Ventures Dalibor MarijanovićPartner at Vesna Advisors Abdelrahman HosnyFounder at ShipBlu Matt HammondPartner at RA Capital

+ 3 more